Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the pharmacokinetics and pharmacodynamics of subcutaneously administered mepolizumab in children with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-11-29